Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
o create an economic model with real world data (RWD) to estimate the clinical and financial impacts of improving the pre-analytical phase of the blood culture practices in England. This will be used to inform future national guidance on specific diagnostics and care pathways for detecting infection and reducing Antimicrobial Resistance (AMR).
Key objectives of this project
To update the model with English RWD wherever possible.
To validate the model inputs, assumptions and results with subject matter experts (SMEs).
To update the report accordingly.
To include additional levels of detail within the model, to more accurately capture the resource use, costs and benefits of optimising the blood culture pathway.
To conduct additional analyses in the existing model, addressing other challenges.
To design and develop a flexible interface for users inputting their own data and generate trust-specific outcomes and business cases.
To develop the report into a manuscript.
To submit the manuscript to a peer-reviewed journal (+/- submission to a pre-print journal) and provide peer-reviewed, referenceable evidence.
Strategic rationale
This aims to support the necessary changes in the blood culture pathway to save lives and improve patient outcomes from sepsis.
Tender notice (UK4). Open for bids. The submission deadline and how to submit are on this notice.
Bids are submitted through the buyer’s own portal, not on this site. Read the full notice on Find a Tender before relying on any date here.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Nov 2026 – Mar 2027 | £72,000 | active |
Weightings from the notice.